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As our toolset to probe the inner work-
ings of biological systems evolves, so too
does our understanding of the molecu-
lar mechanisms involved in disease pro-
cesses. Thus, the importance of energy
metabolism in the pathology of a vari-
ety of disorders is only now beginning to
come to light. To that end, a perturba-
tion in bioenergetics has been attributed as
a major contributing factor to such con-
ditions as aging and carcinogenesis. This
is not surprising since biochemical energy
is required for replication, protein syn-
thesis/turnover, membrane production,
import/export processes, cell signaling,
cellular trafficking, and a myriad of other
bodily functions. It stands to reason then,
that the balance of energy production
and consumption is the fulcrum to main-
taining not only cellular homeostasis, but
also the well-being of the whole organ-
ism. As such, the status of metabolic
pathways that participate in energy pro-
duction can be a strong predictor for
diseases. Indeed, recent molecular, bio-
chemical, and physiological studies tend to
support the hypothesis that cellular energy
status is a determining factor for multiple
disorders (DeBerardinis and Thompson,
2012).
The energy status of the cell orches-
trates an extensive, highly conserved regu-
latory network that balances all aspects of
cellular function. Indeed, AMP-activated
protein kinase (AMPK), a molecular
switch that activates multiple signaling
pathways in response to cellular energy
levels, plays a crucial role in energy
sensing and maintaining cellular home-
ostasis. When energy levels fall within
the cell (AMP/ADP:ATP ratio increases),
AMPK activates, and coordinates cellular
activities in a concerted effort to reduce
ATP usage and increase energy produc-
tion. This includes, but is not limited
to decreasing protein synthesis, lipoge-
nesis, fatty acid production, nucleotide
synthesis, and gluconeogenesis coupled
to an increase in mitochondrial bio-
genesis, glycolysis, glucose uptake, and
autophagy. It is not surprising then that
deregulation of AMPK has been impli-
cated in uncontrolled cell division and
many disease states such as neurode-
generation, diabetes, and inflammation
(Burkewitz et al., 2014). Although exper-
imental evidence suggests that AMPK may
be the conductor of cellular events in
response to cellular energy status, many
other players partake in the orchestration.
Peroxisome proliferator-activated recep-
tor gamma coactivator 1-alpha (PGC-1α),
phosphatase and tensin homolog (PTEN),
uncoupling proteins (UCPs), and sirtu-
ins (SIRT1) that directly or indirectly
respond to cellular energy content are
some of the effectors. These energy reg-
ulators have been the focus of efforts to
develop anti-aging therapeutics and treat-
ments for various disease states such as
cancer, neurodegeneration, and diabetes
(Ortega-Molina and Serrano, 2013). The
importance of these moieties is high-
lighted by the pivotal position they hold in
the crosstalk between cellular energy status
and proper cell functioning.
The necessity of maintaining a balanced
cellular energy status for effective phys-
iological functions places the mitochon-
drion at the center of health and disease.
Indeed, this organelle is the energy pow-
erhouse of the cell, creating the majority
of the ATP used for cellular operation.
Recently, the disturbance of mitochondrial
function has been underscored as a key
feature in the progress of degenerative dis-
orders. For example, genetic mutations
in genes that encode for mitochondrial
machinery have been proposed as a hall-
mark of age-related degenerative disorders
(Wallace, 2013). Moreover, the mitochon-
drion is thought to be at the root of insulin
resistance, metabolic syndrome, cardio-
vascular disease, and cancer (Ren et al.,
2010; Rocha et al., 2014). The impor-
tance of this compartment is amplified in
energy-intensive organs such as the heart,
brain, and muscle tissue. As such, it is not
surprising that mitochondrial dysfunction
and ineffective ATP synthesis have been
linked to a range of disorders that include
cardiac arrhythmias, Parkinson’s disease,
obesity, muscle atrophy, and infertility (Da
Cruz et al., 2012; Wallace, 2013; Youdim
and Oh, 2013). To that end, rejuvenat-
ing the capacity of the mitochondria to
produce energy, increasing mitochondrial
biogenesis as well as the administration
of mitochondria-targeted antioxidants has
received credence as potential therapeu-
tic techniques to alleviate some disorders.
Indeed, the tricarboxylic acid (TCA) cycle
and oxidative phosphorylation, the two
key mediators of ATP production play a
critical role in the health of the mito-
chondria and hence of the bodily func-
tions. The TCA cycle does not only act
as a provider of reducing factors, ingre-
dients that drive ATP synthesis but also
generates metabolites designed to act as
anti-oxidants and regulators of aerobic
respiration. In fact, succinate is known
to promote glycolytic ATP formation, a
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FIGURE 1 | ATP: The molecular key to good health.
feature utilized by rapidly dividing tumors.
The molecular machinations of these ATP-
generating networks may reveal the secrets
underlying good and ill health (Mailloux
et al., 2007).
Hence, maintaining a balanced energy
status in the cell is critical and is orches-
trated by elaborate signaling programs
linked to an intricate feedback regulation
of these energy-producing pathways. This
tightly governed metabolic balancing act is
centered on themitochondrion, the energy
generator of the cell. Indeed, bioenerget-
ics is at the crux of cellular function, and
the dysregulation of energy metabolism
holds the key to the unraveling of dis-
ease conditions (Figure 1). Understanding
the molecular pathways aimed at the gen-
eration and utilization of energy coupled
with their regulation will help unearth
various cellular malfunctions and pave
the way to develop cures against various
maladies.
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